CAS 16153-81-4: 4-(N-Methylpiperazino)aniline

4-(4-Methylpiperazino)aniline is a molecule that has been shown to be orally bioavailable and has a tyrosine kinase inhibitory profile. The kinetic, amide, and safety profiles of this compound have been studied in vitro and in vivo. 4-(4-Methylpiperazino)aniline was found to be safe for use in humans at doses up to 100 mg/kg. The pharmacokinetic profile of this compound suggests that it could be administered as a once-daily oral dose. 4-(4-Methylpiperazino)aniline is being developed as a cancer therapy for the treatment of cancers with epidermal growth factor receptor (EGFR), such as lung cancer, breast cancer, and colorectal cancer.

4-(4-Methylpiperazin-1-yl)aniline

Applications 4-(4-Methylpiperazino)aniline is a reagent in the preparation of benzyloxypyridinone derivative which has c-Met kinase inhibitor properties. References Zhang, D.,et al.: Bioorg. Med. Chem. Lett., 23, 2408 (2013); Gherardi, E., et al.: Nat. Rev. Cancer, 12, 89 (2012)

This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.